However, in our study, the total number of chymase-positive MCs and the number of single chymase-positive MCs both with and without signs of degranulation, as well as their fragments, were statistically significantly lower in the main (COVID-19) group compared to the control. The gene discussed is CMA1; the disease is COVID-19.